Login to Your Account

Pharma: Other News To Note

Thursday, November 21, 2013
• Shire plc, of Dublin, said Intuniv XR (guanfacine hydrochloride extended-release tablets) is now available in Canada for the treatment of attention deficit hyperactivity disorder in children ages 6 to 12.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription